Brand-agnostic solution helps HMEs provide timely PAP replacement
supplies to sleep apnea patients, increases long-term adherence and
improves satisfaction
SAN DIEGO--(BUSINESS WIRE)--
ResMed (NYSE: RMD) (ASX: RMD) today launched its automated ResMed
ReSupply solution for all U.S. home medical equipment (HME) providers to
increase sleep apnea patients’ long-term therapy adherence and improve
patient satisfaction.
Patients enrolled in an automated resupply program are 50 percent less
likely to stop PAP (positive airway pressure) therapy within the first
year, according to a 2018 study. ResMed’s program goes one step further,
automating enrollment as patients meet compliance requirements and
letting patients choose their preferred contact method – text, email or
live call. Patients can also order supplies through a web- or
mobile-based patient portal.
HMEs are able to manage all their patients’ resupply needs from a single
comprehensive dashboard so they can quickly identify, prioritize and
assign tasks.
“The new resupply platform is simple and easy to use – everything you
need is at your fingertips,” said Kera Tennyson, a PAP location manager
at Advanced Medical Solutions, in Ann Arbor, Mich. “PAP is a lifelong
commitment, so it’s important that we help support our patients’ therapy
for the long term. ResMed ReSupply helps us do just that.”
“Automating the resupply process is critical to maximize patients’
success on therapy, as well as HMEs’ business efficiency,” said Raj
Sodhi, ResMed’s SaaS president. “With Brightree offering an automated
resupply solution for its HME customers, and ResMed now launching one
for non-Brightree customers, HMEs using any billing platform can all
enjoy the benefits of an easily managed resupply program.”
HMEs interested in a resupply program can contact their ResMed sales
representative or visit resmed.com/resmedresupply.
Brightree customers can visit https://www.brightree.com/add-on-solutions/patient-resupply/.
Demos of both automated resupply programs will be available at Medtrade
in Las Vegas, April 16–18 (ResMed Booth #527, Brightree Booth #317).
About ResMed
At ResMed (NYSE: RMD) (ASX: RMD) we pioneer innovative solutions that
treat and keep people out of the hospital, empowering them to live
healthier, higher-quality lives. Our cloud-connected medical devices
transform care for people with sleep apnea, COPD and other chronic
diseases. Our comprehensive out-of-hospital software platforms support
the professionals and caregivers who help people stay healthy in the
home or care setting of their choice. By enabling better care, we
improve quality of life, reduce the impact of chronic disease and lower
costs for consumers and healthcare systems in more than 120
countries. To learn more, visit ResMed.com and follow @ResMed.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190325005111/en/
For media:
Jayme Rubenstein
+1 858.836.6798
[email protected]
For investors:
Amy Wakeham
+1 858.836.5000
[email protected]
Source: ResMed